Valora Therapeutics, Inc. — Form D
Valora Therapeutics, Inc. of LA JOLLA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-24. The offering totals $29.2M, of which $13.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-07-24
- Form: D
- Accession: 0002030783-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $29.2M
- Amount sold: $13.0M
- Remaining: $16.1M
- Investors: 12
- Date of first sale: 2024-07-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-519627
Issuer
- Name: Valora Therapeutics, Inc.
- CIK: 0002030783
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 11099 N. TORREY PINES ROAD, LA JOLLA, CA, 92037
- Phone: 858-205-5904
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Miguel Garcia-Guzman | Director | San Diego, CA |
| Stefan Heller | Director | La Jolla, CA |
| Sanford Madigan | Director | La Jolla, CA |
| Miguel Garcia-Guzman | Executive Officer | San Diego, CA |
More